Acute myocardial infarction (AMI) and stroke are important causes of mortality and morbidity. Our aims are to determine the comparative epidemiology of AMI and ischaemic stroke; and examine the differences in cardiovascular outcomes or mortality occurring after an AMI or stroke. 
Introduction
Coronary artery and cerebrovascular diseases are among the top 10 causes of death and disability globally, and contribute substantially to the disability-adjusted life-year loss rate. was higher in patients with acute myocardial infarction (AMI), whereas hypertension was more frequent in stroke patients. 3 In the international REACH Registry, cardiovascular death, myocardial infarction, or stroke rates were 4.52% among patients with coronary artery disease, and 6.47% for patients with cerebrovascular disease at 1 year. 4 In addition to the different risk profile of patients, the burden of AMI and stroke can vary substantially between countries and regions. For example, in a paper published using World Health Organization (WHO) data, there was substantial global variation in the relative burden of stroke compared with ischaemic heart disease. The authors concluded that the disproportionate mortality and morbidity burden from stroke for many lower-income countries suggests that distinct interventions may be required. 2 In Asia, there are limited data on the relative burden and epidemiology of both diseases. This is especially important in Asia where the diverse ethnicities and stages of economic development may offer opportunities for governments to target their interventions more precisely. Therefore, the aims of this study are to (i) determine the comparative risk factor epidemiology of AMI and ischaemic stroke in a largely Asian population and (ii) examine the differences in adverse cardiovascular outcomes or mortality occurring after an index AMI or ischaemic stroke.
Methods
The Singapore National Registry of Diseases Office (NRDO) was established in 2001. Guided by clinicians and mandated by law, the NRDO collects countrywide data on key non-communicable diseases such as AMI, stroke, end-stage renal failure, and cancer. All Singapore residents (citizens and permanent residents) have a unique National Registration Identity Card (NRIC) number, which allows tracking of mortality and hospital admissions. This study utilized AMI, stroke, and death data from the NRDO from 2007 to 2012. Data on clinical outcomes up till 2013 were included.
Coverage: As part of the National Registry of Diseases Act, AMI The proportion of missing data for each of these factors was below 10%.
Index events of AMI and stroke were identified and data were collected as described below. The study included both in-and out-ofhospital deaths, regardless of the place of death that occurred within 1 year from the onset of AMI or ischaemic stroke.
This study was confined to adult (defined as age 15 and above) Singapore residents as the NRIC numbers could be used for matching between the registries. Singapore has a subsidized, affordable and accessible healthcare system, whereby about 95% of AMI and stroke cases are Figure 1 Crude incidence rates of first-ever AMI and ischaemic stroke. All fatal and non-fatal events were included. AMI, acute myocardial infarction. managed at the public hospitals. The use of data collected by NRDO has been previously described. 5 The Institutional Review Board waived the requirement for ethics approval, as the patients whose data were utilized for this study were not identifiable by the study investigators.
Ascertainment of stroke
The methodology of the Singapore Stroke Registry (SSR) has been previously described. 6 
Ascertainment of acute myocardial infarction
The Singapore Myocardial Infarction Registry (SMIR) maintained the AMI registry. AMI was diagnosed if one or more of the following applies: (i) changes in cardiac biomarkers beyond the typical limits applicable to the particular test used, together with symptoms indicative of myocardial ischaemia or electrocardiogram changes indicative of new myocardial ischaemia; (ii) development of new pathological Q waves in the electrocardiogram of the patient; (iii) new loss of viable myocardium or new regional wall motion abnormality; and (iv) fresh thrombus. It includes AMI developed as a complication of cardiovascular intervention for some other cardiac condition. In addition to the sources of data used in case finding for stroke cases, case finding for the SMIR also relied on the list of abnormal cardiac enzymes submitted by each hospital laboratory and notification of AMI deaths that occur at home by general practitioners. These different sources of data provide near to 100% coverage of AMI notifications. ICD-9 code of 410 and ICD-10 codes of I21 and I22 were used to identify AMI cases in the data sources. A separate team of qualified nurses is tasked to perform an annual audit on the data to ensure that the data are accurate.
Episode management
The MONICA (Monitoring Trends and Determinants in Cardiovascular Disease, WHO) criterion was used for episode management for AMI and stroke. 7 Recurrence of AMI or stroke after 28 days of the preceding recorded AMI or stroke episode is counted as another AMI or stroke episode, respectively. The outcomes for this study were non-fatal AMI, nonfatal stroke, or death within 1 year from onset of the index event. The endpoints in the paper are same event (e.g. AMI patient having another AMI episode), different event (e.g. AMI patient having a stroke episode), death, and any of the three types of adverse events. Events are tracked using by matching NRIC records against the AMI, Stroke, and Death Registries. of same event (AMI patient having another AMI episode and ischaemic stroke patient having another stroke episode), occurrence of different event (AMI patient having a stroke episode and ischaemic stroke patient having an AMI episode), death, and any adverse event (same event, different event, or death) within 1 year from onset of the index event. Only variables that are common to both the SMIR and SSR were included in the multivariate logistic regressions to facilitate comparison of odds ratios and their 95% confidence intervals between the two groups of patients. Kaplan-Meier curves for occurrence of event and overall survival within 1 year from onset of the index event were plotted. Statistical analysis was performed using STATA SE (version 13) software. All reported P-values were two-sided and P-values <0.05 were considered to be statistically significant.
Statistical analysis

Results
Between 2007 and 2012, there were 33 222 patients with first-ever AMI and 20 982 with first-ever ischaemic stroke. Crude incidence rate of AMI had increased significantly over the years, whereas crude incidence rate of ischaemic stroke had remained relatively stable as shown in Figure 1 . Table 1 shows the demographic and clinical characteristics of the included patients. Table 2 shows the adjusted odds of the same event occurring within 1 year of the index event. In total 6.8% (2 262/ 33 222) of the AMI patients had a recurrent AMI episode, whereas 4.8% (1 008/20 982) of the ischaemic stroke patients had a recurrent stroke episode within 1 year from the first onset of AMI and ischaemic stroke, respectively. Among the recurrent stroke, 87.9% were ischaemic, 11.5% were haemorrhagic, and 0.6% unknown aetiology. Table 3 shows the adjusted odds of the different event occurring within 1 year of the index event. In total 2.4% (806/33 222) of the AMI patients suffered from a stroke episode, whereas 3.3% (688/ 20 982) of the ischaemic stroke patients suffered from an AMI episode within 1 year from the first onset of AMI and ischaemic stroke, respectively. Among the AMI patients who suffered from a subsequent stroke episode, 89.7% of the stroke episodes were ischaemic, 9.1% were haemorrhagic, and 1.2% were of unknown aetiology.
The risk of having the same event recurring within 1 year from onset of the index event was higher than having a different event, regardless of the patient having had an AMI (Figure 2A ) or ischaemic stroke ( Figure 2B) initially. In both instances, the risk is highest in the first 30 days, as seen by the steeper slope of the curves. In total 31.7% (10 517/33 222) of the AMI patients died, whereas 17.1% (3 589/ 20 982) of the ischaemic stroke patients died within 1 year from the first onset of AMI and ischaemic stroke, respectively. After adjustment for variables that were available to the two registries, the risk of all-cause mortality was higher among older, Malay and diabetic AMI and ischaemic stroke patients. But the risk of death was lower amongst AMI and ischaemic stroke patients who had hypertension Table 4) . Female gender, Indian ethnicity, and smoking were also associated with a lower risk of death in the AMI group. Based on Figure 3 , patients with ischaemic stroke had better survival than patients with AMI (log-rank P-value <0.001). In total, 37.2% (12 369/33 222) of AMI patients died, experienced another AMI episode, or encountered a stroke episode within 1 year from the first onset of AMI; and 22.5% (4 719/20 982) of ischaemic stroke patients died, experienced another stroke episode, or encountered an AMI episode within 1 year from the first onset of ischaemic stroke. Using a composite endpoint of all-cause mortality, AMI and stroke at 1-year, increasing age, Malay ethnicity, and diabetes mellitus were associated with a higher risk for both AMI and stroke groups after accounting for all variables in Table 5 . However, hyperlipidaemia was associated with a lower risk of the composite endpoint for both groups of patients. Among AMI patients, female gender, smokers, and those who had hypertension had a lower risk of experiencing an adverse event of AMI, stroke, or death.
Discussion
Our study is the first to show the differences in risk profiles between AMI and ischaemic stroke patients in an Asian population. Patients suffer recurrent events in vascular territories similar to the index event. One-year mortality is higher after AMI. Age and diabetes mellitus are significant predictors of recurrent vascular events and mortality.
Although the underlying pathology is atherosclerosis for both conditions, the prevalence of traditional risk factors of diabetes mellitus, hypertension, hyperlipidaemia, and smoking is different. Our findings are consistent with the findings of the Dijon Vascular Project and REACH Registry, showing that Asian patients with stroke and AMI have different risk factor profiles. 3, 4 Our finding that stroke patients tend to suffer recurrent stroke as opposed to AMI was also found in REACH. 8 In a meta-analysis of AMI and vascular death occurring after a cerebrovascular accident, Touze et al. 9 found that the annual risk for MI was 2.2%. Comparatively, in a separate review by Witt et al. 10 looking at the incidence of stroke after an AMI, the authors found that approximately 14.5 strokes occurred per 1000 AMI. This compares closely with our findings of 3.3% and 2.4% at 1 year, respectively. Diabetes mellitus is a strong risk factor for vascular disease and was shown in this study to be a consistent predictor of adverse events in both AMI and ischaemic stroke patients, regardless of the index event. In Singapore, the national prevalence (year 2010) of diabetes mellitus is 11.3% in subjects between 18 and 69 years of age.
11 For AMI and ischaemic stroke patients aged 15 and above of this study, diabetes mellitus is seen in 43.8% and 43.1% of the patients, respectively. In the USA, the prevalence is 32% among AMI patients from the American Heart Association Get With The Guidelines Coronary Artery Disease Program 12 and 30% among stroke patients from The Get With The Guidelines-Stroke Program. 13 The high rates of diabetes in the study population, when compared with Western populations, should spur additional research on how diabetes may interact with different ethnic groups. Even within the Singapore population, there is some evidence that diabetes confers a greater risk of heart disease in Indians compared with Malays and Chinese. 14 The results seem to suggest that once AMI or ischaemic stroke occurred, the most important factor is diabetes mellitus. However, it remains unclear if better diabetes mellitus control can improve outcomes. Similarly, certain ethnic groups appear to have worse outcomes. From a public policy perspective, more research is required to understand whether there are cultural or socioeconomic reasons that impede access-to-care, which can be improved or acted upon.
Smoking is a well-established risk factor for incident stroke and AMI. Compared with national prevalence of 24.0% for Singapore residents aged 18-69 (in year 2010), AMI and ischaemic stroke patients with 15 and above years of age have much higher prevalence of 43.1% and 38.6%, respectively. 11 An earlier report by the WHO estimated that up to 30% of cardiovascular (including AMI and stroke) fatalities could be attributable to stroke in the Western-Pacific and South-East Asian regions. 15 Not surprisingly, in our study, smoking is also an independent predictor of the same event recurring after an index AMI or ischaemic stroke. However, smoking did not predict a stroke episode occurring after an index AMI and it was a protective Figure 2 (A) Outcome is AMI whereby survival time is from the first-ever AMI to a second AMI episode for AMI patients and from the first-ever ischaemic stroke to an AMI episode for ischaemic stroke patients within 1 year. A fatal AMI cannot be a recurrent AMI event for AMI patients or a new AMI event for ischaemic stroke patients. (B) Outcome is stroke whereby survival time is from the first-ever AMI to a stroke episode for AMI patients and from the first-ever ischaemic stroke to a second stroke episode for ischaemic stroke patients within 1 year. A fatal stroke cannot be a recurrent stroke event for ischaemic stroke patients or a new stroke event for AMI patients. AMI, acute myocardial infarction. factor against death after an index AMI. This is somewhat surprising given other data showing that smoking predicted mortality after AMI 16, 17 and stroke. [18] [19] [20] The finding that certain ethnic groups were associated with higher rates of recurrent events (Malays and Indians with higher rates of recurrent AMI after an index AMI; Malays with higher rates of a different event and all-cause mortality after an index event) is an important one. Other authors have reported similar findings with Mak et al. 21 showing that Malays and Indians have higher coronary mortality rates than Chinese. Sharma et al. 22 also showed that risk factors for stroke were different in the three ethnic groups, although the short-term outcomes were similar. Possible reasons include genetic predispositions to adverse outcomes, treatment variations and compliance to guideline-recommended therapies and differences in efficacy of medication in selected ethnicities, even in compliant patients. The reasons, if elucidated, can have important public policy impact. Future studies should examine the differential impact of medical therapy and other interventions in these two populations. In both groups of patients, the cornerstone therapies are antiplatelet agents and statins. In some patients with stroke and atrial fibrillation, anticoagulation with warfarin or novel oral anticoagulants would also be indicated. Such medications would normally not be indicated in AMI. Detailed examination on the efficacy of lipid-lowering drugs may also shed light on how lipid management differs between the two groups. Similarly, analysis of diabetic and hypertension treatment and outcomes may yield instructive findings. 
Strengths and limitations
The strengths of the study are that we used countrywide data from two established registries run by a central agency, with standardized definitions and data collection methods, trained staff and strict quality. The number of included patients is large and the estimates are robust. However, the study must also be interpreted in the context of its limitations. This includes the lack of information about the presence of atrial fibrillation as a risk factor in the AMI cohort. Some studies have shown that atrial fibrillation developing after an AMI is a major risk factor for subsequent stroke. 23 Second, the data are constrained by the limitations of retrospectively derived registry information. However, the mandatory data collection across hospitals and the use of a national identity number allow complete capture of events. Furthermore, cases are audited by the NRDO based on manual chart review to ensure accurate case ascertainment.
Conclusions
The prevalence of the traditional risk factors of hypertension, hyperlipidaemia, and smoking is different between patients who present with either a first AMI or ischaemic stroke. Patients suffer recurrent events in vascular territories similar to the index event. One-year mortality is higher after AMI. In our study cohort, diabetes mellitus is strikingly more common than in other populations and is a consistent predictor of adverse events in both AMI and ischaemic stroke patients. There are also ethnic differences that will require further investigation. 
